Zymeworks Inc
NYSE:ZYME
Zymeworks Inc
Other Current Liabilities
Zymeworks Inc
Other Current Liabilities Peer Comparison
Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Other Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Zymeworks Inc
NYSE:ZYME
|
Other Current Liabilities
$8.7m
|
CAGR 3-Years
-40%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
|
Theratechnologies Inc
TSX:TH
|
Other Current Liabilities
$7.6m
|
CAGR 3-Years
29%
|
CAGR 5-Years
35%
|
CAGR 10-Years
20%
|
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
Other Current Liabilities
$10.4m
|
CAGR 3-Years
65%
|
CAGR 5-Years
120%
|
CAGR 10-Years
N/A
|
|
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
|
Other Current Liabilities
$417k
|
CAGR 3-Years
-52%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Other Current Liabilities
$7.5m
|
CAGR 3-Years
46%
|
CAGR 5-Years
106%
|
CAGR 10-Years
9%
|
|
Spectral Medical Inc
TSX:EDT
|
Other Current Liabilities
CA$7.7m
|
CAGR 3-Years
126%
|
CAGR 5-Years
99%
|
CAGR 10-Years
9%
|
See Also
What is Zymeworks Inc's Other Current Liabilities?
Other Current Liabilities
8.7m
USD
Based on the financial report for Dec 31, 2023, Zymeworks Inc's Other Current Liabilities amounts to 8.7m USD.
What is Zymeworks Inc's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 5Y
-13%
Over the last year, the Other Current Liabilities growth was 30%. The average annual Other Current Liabilities growth rates for Zymeworks Inc have been -40% over the past three years , -13% over the past five years .